World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
21265
World Ranking
15287
National Ranking
35

Overview

Peter R. Donald is affiliated with Stellenbosch University in South Africa and conducts research primarily in the field of Medicine. Their work focuses on several subfields including Infectious Diseases, Pharmacology, Immunology, Surgery, and Pediatrics, Perinatology, and Child Health.

The scientist's research interests encompass a range of topics such as Tuberculosis Research and Epidemiology, Immunodeficiency and Autoimmune Disorders, Antibiotics Pharmacokinetics and Efficacy, Infectious Diseases and Tuberculosis, Drug Transport and Resistance Mechanisms, Pharmacological Effects of Natural Compounds, and Immune Responses and Vaccinations.

Among their published papers are:

  • Anton Ghon and His Colleagues and Their Studies of the Primary Focus and Complex of Tuberculosis Infection and Their Relevance for the Twenty-First Century, 2020, Respiration
  • 100 years of Mycobacterium bovis bacille Calmette-Guérin, 2021, The Lancet Infectious Diseases
  • The pharmacokinetics of para-aminosalicylic acid and its relationship to efficacy and intolerance, 2020, British Journal of Clinical Pharmacology
  • Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis, 2022, European Respiratory Journal
  • Tuberculous Meningitis in Children: A Forgotten Public Health Emergency, 2022, Frontiers in Neurology

Frequent coauthors in their research include H. Simon Schaaf, Anneke C. Hesseling, Stephanie Thee, Helen McIlleron, and Paolo Denti.

The scientist's studies have been published predominantly in venues such as Antimicrobial Agents and Chemotherapy, The Lancet Infectious Diseases, European Respiratory Journal, Frontiers in Neurology, and British Journal of Clinical Pharmacology.

Best Publications

  • Tuberculous meningitis: a uniform case definition for use in clinical research

    Suzaan Marais;Guy Thwaites;Johan F Schoeman;M Estée Török

  • The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.

    B J Marais;R P Gie;H S Schaaf;A C Hesseling

  • Childhood pulmonary tuberculosis: old wisdom and new challenges.

    Ben J. Marais;Robert P. Gie;H. Simon Schaaf;Nulda Beyers

  • 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

    Andreas H Diacon;Rodney Dawson;Florian von Groote-Bidlingmaier;Gregory Symons

  • Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance

    A. H. Diacon;P. R. Donald;A. Pym;M. Grobusch

  • Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis.

    J F Schoeman;L E Van Zyl;J A Laubscher;P R Donald

  • Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis

    R. Rustomjee;A. H. Diacon;J. Allen;A. Venter

  • Twenty Years of Pediatric Tuberculous Meningitis: A Retrospective Cohort Study in the Western Cape of South Africa

    G. T. J. van Well;B. F. Paes;C. B. Terwee;P. Springer

  • Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment

    Jakko van Ingen;Rob E. Aarnoutse;Peter R. Donald;Andreas H. Diacon

  • Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis

    Rodney Dawson;Andreas H Diacon;Daniel Everitt;Christo van Niekerk

  • The clinical epidemiology of childhood pulmonary tuberculosis: A critical review of literature from the pre-chemotherapy era

    B J Marais;R P Gie;H S Schaaf;A C Hesseling

  • Evaluation of Young Children in Contact With Adult Multidrug-Resistant Pulmonary Tuberculosis: A 30-Month Follow-up

    H. Simon Schaaf;Robert P. Gie;Magdalene Kennedy;Nulda Beyers

  • Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis.

    D. P. Parkin;S. Vandenplas;F. J. H. Botha;M. L. Vandenplas

  • Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients.

    A H Diacon;R Dawson;M Hanekom;K Narunsky

  • Cerebrospinal fluid concentrations of antituberculosis agents in adults and children

    P.R. Donald

  • Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis

    Helen E Jenkins;Helen E Jenkins;Courtney M Yuen;Courtney M Yuen;Carly A Rodriguez;Ruvandhi R Nathavitharana

  • A PROPOSED RADIOLOGICAL CLASSIFICATION OF CHILDHOOD INTRA-THORACIC TUBERCULOSIS

    Ben J. Marais;Robert P. Gie;H. Simon Schaaf;Jeff R. Starke

  • Early Bactericidal Activity of High-Dose Rifampin in Patients with Pulmonary Tuberculosis Evidenced by Positive Sputum Smears

    A. H. Diacon;R. F. Patientia;A. Venter;P. D. van Helden

  • Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients

    Andreas H. Diacon;Rodney Dawson;Madeleine Hanekom;Kim Narunsky

  • Respiratory tuberculosis in childhood: the diagnostic value of clinical features and special investigations.

    Hendrik S. Schaaf;Nulda Beyers;Robert P. Gie;Etienne D. Nel

Frequent Co-Authors

Nulda Beyers
Nulda Beyers Stellenbosch University
Ben J. Marais
Ben J. Marais University of Sydney
Robin M. Warren
Robin M. Warren Stellenbosch University
Thomas C. Victor
Thomas C. Victor Stellenbosch University
Paul D. van Helden
Paul D. van Helden Stellenbosch University
Peter Smith
Peter Smith University of Aberdeen
Stephen M. Graham
Stephen M. Graham Royal Children's Hospital
Jan L. L. Kimpen
Jan L. L. Kimpen Boston Children's Hospital
Stephen H. Gillespie
Stephen H. Gillespie University of St Andrews
Rifat Atun
Rifat Atun Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but seeking alternative or supplementary pathways to a traditional MD? Online degrees open new doors for both aspiring students and practicing professionals in the medical field. These flexible programs allow you to advance your career or specialize without relocating or pausing work.

For nurses aiming for leadership roles, check out the cheapest online bsn to dnp programs. Pharmacists can expand their qualifications and earning potential through cheapest online pharmacy school options that are cost-effective and accredited.

Healthcare data is a booming sector. Pursuing a degree in health informatics equips you for in-demand roles focused on the ethical management of health information and technology.

Looking for a quick entry into the medical administrative field? Medical coding certification online can help you launch a career in medical billing, coding, and data management—often in a year or less!

Best Scientists Citing Peter R. Donald

Trending Scientists